Back to News
Market Impact: 0.3

Japanese Market Slightly Lower

TMHMCMUFGSMFGMFGSONYDIASPYQQQDAXBNONDAQ
Market Technicals & FlowsPandemic & Health EventsCompany FundamentalsCurrency & FXEnergy Markets & PricesCommodities & Raw Materials
Japanese Market Slightly Lower

Japanese equities, led by the Nikkei 225, are marginally lower by 0.05% on Thursday, extending previous session losses amid mixed global cues and investor caution regarding a potential COVID-19 rebound from the Omicron variant during the New Year's holidays. This follows a mixed performance on Wall Street, where the Dow and S&P 500 achieved new record closing highs despite a slight decline in the Nasdaq. European markets also closed mixed, while crude oil prices advanced on a larger-than-expected draw in U.S. inventories.

Analysis

The Japanese equity market is exhibiting slight weakness, with the Nikkei 225 index declining 0.05% to 28,892.48, reflecting investor caution over the spread of the Omicron variant ahead of the New Year's holidays. This subdued performance follows mixed signals from global markets, where a clear divergence is apparent. While Wall Street saw the Dow Jones Industrial Average rise 0.3% to a new record high for the sixth straight session and the S&P 500 edge up 0.1%, the tech-heavy Nasdaq Composite fell 0.1%. This pattern suggests a rotation into value and cyclical stocks. Within the Japanese market, performance is also fragmented: market heavyweights like SoftBank and Fast Retailing are down, alongside major exporters such as Panasonic and Sony. However, the technology space shows pockets of strength with Advantest and Tokyo Electron adding nearly 1% each, and financials are largely stable. A notable outlier is Z Holdings, which surged almost 6%. Concurrently, crude oil prices are strengthening, with February futures climbing 0.8% to $76.56 a barrel following a larger-than-expected drop in U.S. inventories, indicating robust underlying demand.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo